Professeur titulaire en hépatologie et pharmacologie clinique

Chef du service de médecine intern

Chercheur principal ou co-investigateur pour la phase 1, 2 et / ou 3 pour des études Anadys, Bristol Meyers Squibb, Chiesi, Eli-Lilly, GlaxoSmithKline, Innogenetics, Novartis, Merck, Pfi zer, Roche, Sanofi-Aventis, Schering-Plough, Servier, Solvay, U.C.B., Vertex, Debio, Gilead, Boehringer Ingelheim…

Publications: auteur ou co-auteur de livres et de plus de 250 articles principalement consacrés à l’hépatologie et à la pharmacologie clinique

Promoteur de 9 thèses biomédicales en gastro-entérologie ou pharmacologie clinique.

Spécialiste en Médecine Interne (ULB 1983) et Pneumologie (ULB 1983) Boursier de la Fondation Erasme et de la Fondation Roi Baudouin 1985-1986 Agrégé de l’Enseignement supérieur en 1988. « Contribution des Analyses Minéralogiques à l’identification des Pathologies Respiratoires liées à l’Amiante »

Chef de Service de Pneumologie à l’Hôpital Erasme depuis 1996. Professeur de Pneumologie à l’ULB ( Ma 1 et Ba 3) depuis 2000 (Chargé de Cours)

Professeur en évaluation du dommage corporel (expertise) Membre du Conseil Technique du Fonds des Maladies Professionnelles Président de la Commission d’agrément en Pneumologie (F)

Auteur d’environ 100 publications dans des revues internationales à comité de lecture et d’environ 150 présentations dans des congrès internationaux. Orateur invité aux congrès de l’European Respiratory Society, de l’American Thoracic Society et de la Société de Pneumologie de Langue Française. Orateur invité à l’Académie Royale de Médecine ( 2014)

Thèmes de recherche et domaines de prédilection :
Affections respiratoires professionnelles et environnementales (pneumoconioses, mésothéliome). Chairman du groupe « Occupational and Environmental Scientific Group de l’European Respiratory Society ( 1998-2002) Pathologies interstitielles diffuses (PID) et en particulier la fibrose pulmonaire idiopathique (FPI) et les PID secondaires aux expositions environnementales et iatrogènes.

Auteur et acteur des Revues satiriques de l’hôpital Erasme

Professeur de Pharmacologie, Neuropsychiatre, Chef du Service de Pharmacologie Clinique, Marseille, France

Chef de Service de Pneumologie à l’Hôpital Erasme depuis 1996. Professeur de Pneumologie à l’ULB ( Ma 1 et Ba 3) depuis 2000 (Chargé de Cours)

Prof. Olivier BLIN (M.D., Ph.D, MBA) is currently the Head of Clinical Pharmacology Dpt in Marseille University Hospital (France), VP of Scientific Council for High Council for Strategic Training and Research (France). Past member of the Board of the French Minister of Health and founding VP of the Competitiveness Cluster Eurobiomed, he spent one year in India (2010) to enhance the collaboration between French and Indian clusters. He is past Associated Prof at Imperial College (London) and also spent 2 years in Shanghai(2011-2013), leading the global CNS discovery medicine for GSK. He set up the IMI PharmaCog consortium (2010-2014). He recently joined the Scientific Council of Aviesan (Neurosciences). Olivier Blin authored more than 200 papers, is the co-founder of several start-up.

Chef de Service honoraire d'Endocrinologie, Diabétologie et Nutrition aux Cliniques Universitaires Saint-Luc, 1200 Bruxelles

Professeur (Emérite) d’Endocrinologie à l'Université catholique de Louvain

Professeur Affilié à l’Université de Porto (Portugal)

Président de la revue Louvain Médical

Membre du Conseil d’Administration de la Fondation Francophone pour la Recherche pour le Diabète (Paris)

Président ff de l’AMA-UCL (Alumni UCL)

President de l’Association Belge du Diabète

Membre de “Diabetes India”

Membre honoraire de la Société Portugaise de Diabétologie

Auteur de plus de 400 publications dans des revues nationales et internationales

Eric Van Cutsem obtained his MD and PhD degree and trained in internal medicine and gastroenterology/GI oncology at the University of Leuven, Belgium.

Eric Van Cutsem trained in internal medicine and gastroenterology in Leuven and specialised later in GI oncology in Leuven, Belgium. He is currently Professor of Internal Medicine at the University of Leuven and is head of the Digestive Oncology Unit at the University Hospital Gasthuisberg in Leuven. He is also a board member of Leuven Cancer Institute and of the Department of Oncology at the University of Leuven. He obtained his degree of MD and PhD at the University of Leuven.

He has a large clinical activity in Leuven and is involved and leads many national and international clinical and translational research projects on gastrointestinal cancer.

Prof. Van Cutsem has published more than 340 peer-reviewed articles (on pubmed; H-factor: 70; >20000 citations) in prestigious journals including New England Journal Medicine, Journal of Clinical Oncology, Lancet, Lancet Oncology, JAMA, Annals of Oncology and European Journal of Cancer. He is co-editor of the reference textbook on gastrointestinal cancer: Principles and Practice of Gastrointestinal Oncology: Second edition, 2008, and is/has been an editorial board member of numerous prestigious journals, including Journal of Clinical Oncology, Annals of Oncology, and European Journal of Cancer and is associated editor of Targeted Oncology and editor of European Journal Cancer since January 2011.

Eric Van Cutsem is a member of several scientific organisations. He is/was a member of the Scientific Programme Committee and/or Educational Committee of ASCO, ASCO-GI cancers symposium, ESMO and ECCO. He is also a member of the ESMO faculty and joined the ESMO Executive Board on July 1, 2011. He served as Secretary of the European Organisation for Research and Treatment of Cancer – Gastrointestinal Cancer (EORTC-GI) group from January 2000 to 2003, and was Chair of the EORTC-GI group from 2003 to 2007 and is Chairman of PETACC (Pan-European Trials on Adjuvant Colon Cancer) since 2008, Board Member of the EORTC since 2009, President of European Society of Digestive Oncology (ESDO) and Co-Chairman of the European NeuroEndocrine Tumour Society (ENETS) registry. He is also Chairman of the Governmental Colon Cancer Prevention Task Force in Flanders, Belgium and is President of BGDO (Belgian Group Digestive Oncology) and FAPA (Familial Adenomatous Polyposis Association). Eric Van Cutsem has been the founder of and is Chair of the Scientific Committee of the World Congress on Gastrointestinal Cancer in Barcelona (in partnership with ESMO since 2005).

Prof Eric Constant, M.D., Ph.D.

Head of Adult Psychiatry Department

Institute of Neurosciences IoNS

Cliniques Universitaires St-Luc

Coordinateur médical Clinique SANATIA

Université catholique de Louvain, Belgium

Martine De Vos obtained her MD and PhD degree and trained in internal medicine and gastroenterology at the University Gent, Belgium.

She is currently Full Professor in Gastroenterology at University Gent , Belgium and head of department of gastroenterology as well head of department of Internal medicine at the University Hospital Gent.

She published more than 200 peer reviewed articles. Her main research is focused on inflammatory bowel diseases.

Her current translational research is focused on new possible targets for therapy.

Clinical activity and basic research including different animal models and in vitro models are grouped in “ IBD-centrum UZGent”.

She is also a experienced endoscopist with specific interest in ERCP Martine De Vos is member of several scientific organisations . She was the president of Belgian IBD research group and board member of Belgian Society of Endoscopy and Flemish society of Gastroenterology.

She developed and implemented the master of specialist medicine.

Dept of Clinical Hematology
Institut Jules Bordet, Bruxelles (B)

Dominique Bron is Professor of Hematology at the Free University of Brussels (ULB) and Head of the department of clinical and experimental haematology at the Institut Jules Bordet, the cancer centre of the ULB.

Professor Bron was graduated in Internal Medicine in 1984 and received her PhD in 1990. During her training in Internal Medicine, she acquired particular expertise in Onco-hematology after eighteen months of postgraduate work with Professor H. Kaplan of Stanford University, California and well as with Professor D. Thomas, director of the Bone Marrow Transplant Unit of Seattle, Washington.
Prof. Bron contributed to the development of the research laboratory of Prof. P. Stryckmans with her work on chronic lymphoid leukaemia and hematopoietic stem cells.

Prof. Bron is a member of the American Society of Hematology, the International Society of Experimental Hematology, the European Society of Hematology, the EBMT and the EORTC, the International Society of Supportive Care in Oncology. She is currently member of the board of the EHA (involved in education and outreach activities)

Prof. Bron is the author of more than 150 scientific publications, and more than 500 communications in national and international congresses.

She is honorary professor at the University of Ho Chi Minh and at the University of Prague.

Prof. Bron is also concerned with ethical questions being active member of the Ethical Review Board at the Institut Jules Bordet for more than 30 years.

She is past president of the Belgian Society of Hematology and member of the Royal Academy of Medecine of Belgium.

Certificate of humanities Latin-Science: june 1965, Koninklijk Atheneum Etterbeek, Brussels

Licence in physical education, VUB in 1970
Doctor in Medicine, VUB: 30th of June 1972.
Certificate of sports medicine ULB in 1973.
Postgraduate in dermatology and venereology during academic years 1973-1976, in department of Prof. Achten, St.-Pieters- and Brugmannhospital, ULB-VUB.

Specialisation in dermatology and venereology, attributed in October 1976.
Postdoctoral training : in the laboratory of the “Department of Dermatology” of the University of Michigan in Ann Arbor U.S.A., under the leadership of Prof. Dr. J.J. Voorhees. From oktober 1978 ‑ January 1981.

PhD and Authorized of high education in dermatological and venereological sciences since March, 28th 1983.
Founding member of the “Belgian Association of Dermato‑Cosmetic Sciences B.A.D.E.C.O.S. November 1989. Vice‑President of B.A.D.E.C.O.S. ‑ November Two meetings/year till 2006.

Fouding member and Vice-president of the “European Society for Micrographic Surgery” – 1990-1995.
Vice-President en adjunct secretary of the “Koninklijke Belgische Vereniging voor Dermatologie en Venereologie” – 1991-1993, 1994-1995

President of the “Royal Belgian Society of Dermatology and Venereology” – March 1995 – 1999
Organiser and President of the 4th Congress of the European Academy of Dermatology and Venereology (EADV), 10-15 october 1995 in Brussels, (congress with 3000 participants).
Treasurer of the European Academy of Dermatology and Venereology - October 1995-October 2001.

Founding member and teacher of the “Intensive Course in Dermato-Cosmetics” from 1998 – now

Head of the department of dermatology UZ Brussels (U
niversity Hospital of Free University of Brussels)
Professor of dermatology and venereology at the VUB Full-time recognized supervisor of trainees in Dermatology and Venereology in the UZ Brussel from 1985 on.

103 communications at National Congresses with 242 as first author and 187 communications with 124 as first author at International Congresses. 185 publications in national and international Journals with 52 as first author.

Participation and experience in clinical trials since 1976

(more than 90 studies).

Alain Dupont, MD, PhD, geboren op 4 maart 195,

is internist-klinisch farmacoloog en gewoon hoogleraar, hoofd van het departement Farmacologie aan de Vrije Universiteit Brussel en hoofd van de dienst Klinische Farmacologie en Farmacotherapie van het Universitair Ziekenhuis Brussel waar hij ook de hypertensiekliniek leidt, en het Medisch Farmaceutisch Comité voorzit.

Hij was vicedecaan onderzoek gedurende 4 jaar en momenteel (sinds september 2008) is hij decaan van de faculteit Geneeskunde en Farmacie. Hij is lid van de Raad van Bestuur van het UZ Brussel en van de Raad van Bestuur van de VUB.

Hij was stichtend voorzitter en lid van de Commissie Tegemoetkoming Geneesmiddelen en is lid van de Raad van Bestuur en voormalig voorzitter van de raad van Bestuur van het Belgisch centrum voor Farmacotherapeutische Informatie.

Hij combineerde zijn academische functies met verschillende leidinggevende functies bij Johnson & Johnson van november 1991 tot februari 2000.

Zijn onderzoek is gericht op hypertensie, cardiovasculaire farmacologie en farmacotherapie. Hij ontving 3 wetenschappelijke prijzen, is auteur en co-auteur van meer dan 150 artikels in ‘peer reviewed’ tijdschriften en boeken, en promotor van verschillende doctoraten.

Robert Andrianne, professor of Sexual Medicine is senior urologist (chef de clinique) in the Urologic department at the University Hospital of Liège in Belgium.

1.Career: 1979, degree in Medicine University of Liège – 1985, degree as Specialist in Urology, University of Liège – 1987, degree in Clinical Sciences, PHD – 2009, Professor of Sexual Medicine University of Liège - Since 1985 Founder and Clinical Director of the Center of exploration and treatment of sexual insufficiency (CETISM) – Since 1995 Course in the Medical Public school of University of Liège in Sexology – 2005-2007 – Chairman of the Belgian Society of Urology 2005-2007 – Since 1997 Society of Belgian university of sex therapist (SSUB)

2.Societies: Member of numerous national and international association, including the French and American Urological Associations. AMLg, Belgian Society of Urology (President from 2005 to 2006), French Society of Andrology, French Society of Urology 1989, European Association of Urology (EAU) 1989, Belgian Section of the International Society of Urology since 2.12.1989, American Association of Urology 1990, Society of Academic Sexologists of Belgium since 1997, International Society of Sexual Medecine and European Society of Sexual Medecine (ISSM-ESSM) French Society of Sexual Medecine (founding member 2005), Belgian Society of Sexual Medecine- BeSSM (founding member 2008), Federation of the Association and Society of French-speaking Urologist (FASULP) (Founding member 2008)

3:Research: In addition to teaching and clinical practice (CHU of Liège), Robert Andrianne was in Belgium investigator for clinical trials on investigational treatment options for male sexual problems in different situations. Scientific activity of Robert Andrianne is more than 50 full papers on peer-reviewed international and national journals – co-Redactor of the french journal « Progrès en Urologie » from 2001 to 2006 Main research interests are andrology and sexual medicine, with special emphasis on erectile dysfunction, penile prosthesis revalidation, bibliotherapy in PE, andrology and urolithiasis. Robert Andrianne is the largest implanter of penile prosthesis in Belgium.

Adrian Ivanoiu est neurologue à la Clinique Saint Luc, Bruxelles, professeur de neurologie et membre de l’Institut de Neuroscience de l’UCL.

Il s’est intéressé très tôt dans sa formation aux troubles cognitifs résultant d’une lésion cérébrale ou d’un processus de vieillissement pathologique.

Il a défendu une thèse de doctorat en 2004 intitulée “Cognitive and biological markers of mild cognitive impairment and early Alzheimer's disease” sous la direction des Professeurs Emile-Christian LATERRE et Xavier SERON. Il a eu l’occasion de participer à des recherches dans le domaine des démences dégénératives avec le Professeur John R. Hodges à Cambridge, UK.

Il est un expert reconnu dans son domaine en Belgique et à l’étranger, Vice-Président de la Société Belge de Neurologie et Président du « Belgian Dementia Council ». Il pratique la clinique à la consultation spécialisée « la Clinique de la Mémoire » à Saint Luc et ses intérêts de recherche concernent l’étude de la cognition et des marqueurs biologiques des démences dégénératives.

Médecin généraliste
Professeur honoraire de l’Université Libre de Bruxelles.
Président de l’Association Belge des Syndicats Médicaux (ABSyM).
Président de la Chambre Syndicale des Médecins du Hainaut-Namur et Brabant wallon.
Représentant de l’ABSyM dans les instances INAMI suivantes :

Commission Nationale Médico-Mutuelliste.
Comité de l’Assurance.
Conseil général.
Commission de Remboursement de Médicaments.
Conseil Technique Médical.
Groupe de Direction de l’Accréditation.
Conseil National de la Promotion de la Qualité.
Président du Groupe de Travail de Médecine Générale du Conseil Supérieur des Médecins Généralistes et des Médecins Spécialistes de SPF Santé Publique.
Membre du Conseil Supérieur des Médecins Généralistes et des Médecins Spécialistes de SPF Santé Publique.
Membre effectif du Commission de Planification de l’offre médicale de SPF Santé Publique.
A été Secrétaire général de l’Académie Européenne de la Formation Médicale Continue.

En charge des affaires internationales de l’ABSyM pendant plus de 20 ans, a été notamment :

Président de la Commission d’Ethique et de Déontologie du Comité Permanent des Médecins Européens (CPME).
Vice-président au Comité Permanent des Médecins Européens.
Trésorier du CPME.
Conseiller au Comité d’éthique de l’Association Médicale Mondiale.
Membre du Comité de liaison de l’European Forum of Medical Associations (EFMA)
Membre et trésorier de l’EANA (Groupement européen des médecins en pratique libre).

Docteur en médecine en 1975 interne des hôpitaux de Nancy de 1971 à 1975 Chef ce clinique ,assistant des hôpitaux de Rouen 1976,1977

Installation à la clinique

Le Petit Colmoulins de 1977 à 2010 comme chirurgien urologue au Havre DESS de management des établissements de soins et des réseaux en 2000 Compétence en carcinologie urologique en 2003 Évaluateur interne certifié en 2010 Pensionné en 2010

Voormalig hoofdapotheker aan het Universitair Ziekenhuis Gent (-2013)

Was Gastprofessor (farmaco-economie en beheer&management van de ziekenhuisapotheek) aan de Faculteit Farmaceutische Wetenschappen (-2013)

Academisch consulent aan de Faculteit Farmaceutische Wetenschappen (2013-)

Ondervoorzitter van de Commissie Terugbetaling Geneesmiddelen (CTG-CRM) (2002-)

Voorzitter van de Erkenningscommissie voor ziekenhuisapothekers (2006-)